Email
Print
Antipsychotic Drugs Market - Forecast(2024 - 2030)
Antipsychotic Drugs Market Report
Overview
The Antipsychotic Drugs market size is $14.96 billion in 2018. The global Antipsychotic Drugs Market has been forecasted to reach $19.74 billion by 2025, growing at a CAGR of 4.0% during the forecast period 2019-2025. The market is currently witnessing a growth owing to the increasing prevalence of psychotic disorders reported globally. Also, the huge investments for research and development to create new drugs are further fueling market growth.
Key Takeaways
The North America region has been estimated to
hold the largest revenue share owing to the higher prevalence of psychotic
disorders in the region as well as the greater availability of advanced
healthcare.
The growing prevalence of psychotic disorders worldwide
is said to drive the market growth. Companies are also investing in research
for developing better drug formulations for combating these mental disorders.
The drugs used for the treatment of these
disorders is known to cause addiction if taken in higher quantities. This is
considered as a major challenge to the overall market.
Drug Class - Segment Analysis
The second generation drug class
holds the largest share in the drug class segment due to having less side
effects and higher therapeutic efficiency. However, the third generation drugs
are said to have the fastest growth rate with CAGR of 3.5% during the forecast
period, owing to the safety and tolerability compared to other generation of
drugs. Commonly administered antipsychotic drugs include perphenazine, thiothixene, chlorpromazine hcl, haloperidol, loxapine succinate and others.
Application Type - Segment Analysis
The application of the drugs in
the treatment of schizophrenia is estimated to hold the largest share currently.
As per WHO, Schizophrenia affects 20 million people worldwide. However,
depression is the most common mental disorder affecting all ages and is said to
have the fastest growth rate.
Geography - Segment Analysis
The North America region has been
estimated to dominate the Antipsychotic Drugs market share with 46%. This is
owing to the increasing prevalence of disorders. As per the U.S. National
Institute of Mental Health, the prevalence of schizophrenia and related
psychotic disorders range between 0.25% and 0.64% in the U.S. Also, Asia
Pacific is likely to have a faster growth rate in the coming years due to
growing population, increasing healthcare expenditure and increasing awareness
programs regarding the usage of these drugs.
Drivers – Antipsychotic Drugs Market
Increasing Prevalence of
Psychotic Disorders
The overall
global prevalence of psychotic disorders like schizophrenia and depression is
increasing at a quick rate. This factor has the potential to be a major market
driver for the antipsychotic drugs market. Growing awareness regarding the
complications of these disorders and the appropriate treatment is set to fuel
the market growth.
Funding
for Research and Development
There is a
significant rise in the funding for the research and development of effective
newer formulations with lesser side effects. This could also be considered as a
major market driver as new funding into the research and development could
increase the chance of the discovery of a new product to treat psychotic
disorders.
Challenges – Antipsychotic Drugs Market
Risk of
Addiction
These drugs, when over
prescribed, could cause severe complications and also addiction. People are
increasingly becoming aware of these problems and this can prove to be a major
market constraint. This is more apparent for the people from the more developed
parts of the world like North America. This has forced the governments to have
even stronger regulations regarding these drugs further limiting the market
growth.
Antipsychotic Drugs Industry Outlook
Partnerships and product launches are the key
strategies adopted by the major players in the antipsychotic drugs market. Antipsychotic
Drugs top 10 companies are Eli Lilly and Company, AstraZeneca, Pfizer Inc., GlaxoSmithKline
PLC, Johnson & Johnson, Allergan, Bristol-Myers Squibb, Actavis Generics, Alkermes,
and Otsuka Pharmaceutical Co., Ltd.
Developments:
On
May 2019, Vraylar from Allergan got an approval from the FDA for the treatment
of depressive episodes of bipolar disorder. The company claims that this
product will bring in a sales of $683 million in 2019.
On
March 2015, GSK had become a partner in a new global fund that is focused on
dementia research. The company had provided an investment of $25 million
dollars.
Antipsychotic Drugs Market
Research Scope:
The base year of the study is 2018, with forecast done
up to 2025. The study presents a thorough analysis of the competitive
landscape, taking into account the market shares of the leading companies.
These provide the key market participants with the necessary business
intelligence and help them understand the future of the Antipsychotic Drugs
Market. The assessment includes the forecast, an overview of the competitive
structure, the market shares of the competitors, as well as the market trends,
market demands, market drivers, market challenges, and product analysis. The
market drivers and restraints have been assessed to fathom their impact over
the forecast period. This report further identifies the key opportunities for
growth while also detailing the key challenges and possible threats.
1. Antipsychotic Drugs Market - Overview
1.1 Definitions and Scope
2. Antipsychotic Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Antipsychotic Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Antipsychotic Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Antipsychotic Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Antipsychotic Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Antipsychotic Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Antipsychotic Drugs Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Antipsychotic Drugs Market - By Drug Class (Market Size -$Million / $Billion)
9.1 First Generation/Standard/Typical Antipsychotic Drug
1.1 Definitions and Scope
2. Antipsychotic Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Antipsychotic Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Antipsychotic Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Antipsychotic Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Antipsychotic Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Antipsychotic Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Antipsychotic Drugs Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Antipsychotic Drugs Market - By Drug Class (Market Size -$Million / $Billion)
9.1 First Generation/Standard/Typical Antipsychotic Drug
9.2 Haldol Market
9.3 Navane Market
9.4 Other Market
9.5 Second Generation/Atypical Antipsychotic Drug
9.6 Zyprexa Market
9.7 Seroquel Market
9.8 Risperdal Market
9.9 Invega Market
9.10 Latuda Market
9.11 Others Market
9.12 Third Generation Antipsychotic Drug
10. Antipsychotic Drugs - By Application Type (Market Size -$Million / $Billion)
10.1 Schizophrenia
10.2 Bipolar Disorder
10.3 Depression
10.1 Schizophrenia
10.2 Bipolar Disorder
10.3 Depression
10.4 Dementia
10.5 Other Psychotic Disorder
11. Antipsychotic Drugs- By Geography (Market Size -$Million / $Billion)
11.1 Antipsychotic Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Antipsychotic Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Antipsychotic Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Antipsychotic Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Antipsychotic Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Antipsychotic Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Antipsychotic Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Antipsychotic Drugs Market - Key Company List by Country Premium
15. Antipsychotic Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Allergan
15.3 Astrazeneca
15.4 Bristol-Myers Squibb Company
15.5 Eli Lilly Co
15.6 Geographic Foothold
15.7 Glaxo Smithkline, Plc
15.8 Johnson Johnson
15.9 Pfizer, Inc
15.10 Company 9
15.11 Company 10 & More
16.1 Abbreviations
16.2 Sources
17. Antipsychotic Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
11. Antipsychotic Drugs- By Geography (Market Size -$Million / $Billion)
11.1 Antipsychotic Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Antipsychotic Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Antipsychotic Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Antipsychotic Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Antipsychotic Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Antipsychotic Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Antipsychotic Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Antipsychotic Drugs Market - Key Company List by Country Premium
15. Antipsychotic Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Allergan
15.3 Astrazeneca
15.4 Bristol-Myers Squibb Company
15.5 Eli Lilly Co
15.6 Geographic Foothold
15.7 Glaxo Smithkline, Plc
15.8 Johnson Johnson
15.9 Pfizer, Inc
15.10 Company 9
15.11 Company 10 & More
*Financials would be provided on a best efforts basis for private companies
16. Antipsychotic Drugs Market - Appendix16.1 Abbreviations
16.2 Sources
17. Antipsychotic Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)1.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Global Industry Research
1.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
1.2 Haldol Market Market 2019-2024 ($M) - Global Industry Research
1.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
1.3 Navane Market Market 2019-2024 ($M) - Global Industry Research
1.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
1.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Global Industry Research
1.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
1.6 Zyprexa Market Market 2019-2024 ($M) - Global Industry Research
1.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
1.7 Seroquel Market Market 2019-2024 ($M) - Global Industry Research
1.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
1.8 Risperdal Market Market 2019-2024 ($M) - Global Industry Research
1.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
1.9 Invega Market Market 2019-2024 ($M) - Global Industry Research
1.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
1.10 Latuda Market Market 2019-2024 ($M) - Global Industry Research
1.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
1.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Global Industry Research
1.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
2.Global Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
2.1 Schizophrenia Market 2019-2024 ($M) - Global Industry Research
2.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
2.2 Bipolar Disorder Market 2019-2024 ($M) - Global Industry Research
2.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
2.3 Depression Market 2019-2024 ($M) - Global Industry Research
2.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
2.4 Dementia Market 2019-2024 ($M) - Global Industry Research
2.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
3.Global Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 (Volume/Units)
3.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 (Volume/Units) - Global Industry Research
3.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.2 Haldol Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.2.1 Haldol Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.3 Navane Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.3.1 Navane Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 (Volume/Units) - Global Industry Research
3.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.6 Zyprexa Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.7 Seroquel Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.7.1 Seroquel Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.8 Risperdal Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.8.1 Risperdal Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.9 Invega Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.9.1 Invega Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.10 Latuda Market Market 2019-2024 (Volume/Units) - Global Industry Research
3.10.1 Latuda Market Estimate Forecast Market 2019-2024 (Volume/Units)
3.12 Third Generation Antipsychotic Drug Market 2019-2024 (Volume/Units) - Global Industry Research
3.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 (Volume/Units)
4.Global Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 (Volume/Units)
4.1 Schizophrenia Market 2019-2024 (Volume/Units) - Global Industry Research
4.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 (Volume/Units)
4.2 Bipolar Disorder Market 2019-2024 (Volume/Units) - Global Industry Research
4.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 (Volume/Units)
4.3 Depression Market 2019-2024 (Volume/Units) - Global Industry Research
4.3.1 Depression Market Estimate Forecast Market 2019-2024 (Volume/Units)
4.4 Dementia Market 2019-2024 (Volume/Units) - Global Industry Research
4.4.1 Dementia Market Estimate Forecast Market 2019-2024 (Volume/Units)
5.North America Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)
5.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
5.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
5.2 Haldol Market Market 2019-2024 ($M) - Regional Industry Research
5.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
5.3 Navane Market Market 2019-2024 ($M) - Regional Industry Research
5.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
5.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
5.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
5.6 Zyprexa Market Market 2019-2024 ($M) - Regional Industry Research
5.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
5.7 Seroquel Market Market 2019-2024 ($M) - Regional Industry Research
5.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
5.8 Risperdal Market Market 2019-2024 ($M) - Regional Industry Research
5.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
5.9 Invega Market Market 2019-2024 ($M) - Regional Industry Research
5.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
5.10 Latuda Market Market 2019-2024 ($M) - Regional Industry Research
5.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
5.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
5.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
6.North America Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
6.1 Schizophrenia Market 2019-2024 ($M) - Regional Industry Research
6.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
6.2 Bipolar Disorder Market 2019-2024 ($M) - Regional Industry Research
6.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
6.3 Depression Market 2019-2024 ($M) - Regional Industry Research
6.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
6.4 Dementia Market 2019-2024 ($M) - Regional Industry Research
6.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
7.South America Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)
7.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
7.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
7.2 Haldol Market Market 2019-2024 ($M) - Regional Industry Research
7.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
7.3 Navane Market Market 2019-2024 ($M) - Regional Industry Research
7.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
7.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
7.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
7.6 Zyprexa Market Market 2019-2024 ($M) - Regional Industry Research
7.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
7.7 Seroquel Market Market 2019-2024 ($M) - Regional Industry Research
7.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
7.8 Risperdal Market Market 2019-2024 ($M) - Regional Industry Research
7.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
7.9 Invega Market Market 2019-2024 ($M) - Regional Industry Research
7.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
7.10 Latuda Market Market 2019-2024 ($M) - Regional Industry Research
7.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
7.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
7.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
8.South America Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
8.1 Schizophrenia Market 2019-2024 ($M) - Regional Industry Research
8.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
8.2 Bipolar Disorder Market 2019-2024 ($M) - Regional Industry Research
8.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
8.3 Depression Market 2019-2024 ($M) - Regional Industry Research
8.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
8.4 Dementia Market 2019-2024 ($M) - Regional Industry Research
8.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
9.Europe Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)
9.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
9.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
9.2 Haldol Market Market 2019-2024 ($M) - Regional Industry Research
9.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
9.3 Navane Market Market 2019-2024 ($M) - Regional Industry Research
9.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
9.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
9.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
9.6 Zyprexa Market Market 2019-2024 ($M) - Regional Industry Research
9.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
9.7 Seroquel Market Market 2019-2024 ($M) - Regional Industry Research
9.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
9.8 Risperdal Market Market 2019-2024 ($M) - Regional Industry Research
9.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
9.9 Invega Market Market 2019-2024 ($M) - Regional Industry Research
9.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
9.10 Latuda Market Market 2019-2024 ($M) - Regional Industry Research
9.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
9.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
9.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
10.Europe Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
10.1 Schizophrenia Market 2019-2024 ($M) - Regional Industry Research
10.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
10.2 Bipolar Disorder Market 2019-2024 ($M) - Regional Industry Research
10.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
10.3 Depression Market 2019-2024 ($M) - Regional Industry Research
10.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
10.4 Dementia Market 2019-2024 ($M) - Regional Industry Research
10.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
11.APAC Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)
11.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
11.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
11.2 Haldol Market Market 2019-2024 ($M) - Regional Industry Research
11.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
11.3 Navane Market Market 2019-2024 ($M) - Regional Industry Research
11.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
11.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
11.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
11.6 Zyprexa Market Market 2019-2024 ($M) - Regional Industry Research
11.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
11.7 Seroquel Market Market 2019-2024 ($M) - Regional Industry Research
11.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
11.8 Risperdal Market Market 2019-2024 ($M) - Regional Industry Research
11.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
11.9 Invega Market Market 2019-2024 ($M) - Regional Industry Research
11.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
11.10 Latuda Market Market 2019-2024 ($M) - Regional Industry Research
11.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
11.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
11.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
12.APAC Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
12.1 Schizophrenia Market 2019-2024 ($M) - Regional Industry Research
12.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
12.2 Bipolar Disorder Market 2019-2024 ($M) - Regional Industry Research
12.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
12.3 Depression Market 2019-2024 ($M) - Regional Industry Research
12.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
12.4 Dementia Market 2019-2024 ($M) - Regional Industry Research
12.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
13.MENA Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2019-2024 ($M)
13.1 First Generation/Standard/Typical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
13.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2019-2024 ($M)
13.2 Haldol Market Market 2019-2024 ($M) - Regional Industry Research
13.2.1 Haldol Market Estimate Forecast Market 2019-2024 ($M)
13.3 Navane Market Market 2019-2024 ($M) - Regional Industry Research
13.3.1 Navane Market Estimate Forecast Market 2019-2024 ($M)
13.5 Second Generation/Atypical Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
13.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2019-2024 ($M)
13.6 Zyprexa Market Market 2019-2024 ($M) - Regional Industry Research
13.6.1 Zyprexa Market Estimate Forecast Market 2019-2024 ($M)
13.7 Seroquel Market Market 2019-2024 ($M) - Regional Industry Research
13.7.1 Seroquel Market Estimate Forecast Market 2019-2024 ($M)
13.8 Risperdal Market Market 2019-2024 ($M) - Regional Industry Research
13.8.1 Risperdal Market Estimate Forecast Market 2019-2024 ($M)
13.9 Invega Market Market 2019-2024 ($M) - Regional Industry Research
13.9.1 Invega Market Estimate Forecast Market 2019-2024 ($M)
13.10 Latuda Market Market 2019-2024 ($M) - Regional Industry Research
13.10.1 Latuda Market Estimate Forecast Market 2019-2024 ($M)
13.12 Third Generation Antipsychotic Drug Market 2019-2024 ($M) - Regional Industry Research
13.12.1 Third Generation Antipsychotic Drug Market Market 2019-2024 ($M)
14.MENA Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
14.1 Schizophrenia Market 2019-2024 ($M) - Regional Industry Research
14.1.1 Schizophrenia Market Estimate Forecast Market 2019-2024 ($M)
14.2 Bipolar Disorder Market 2019-2024 ($M) - Regional Industry Research
14.2.1 Bipolar Disorder Market Estimate Forecast Market 2019-2024 ($M)
14.3 Depression Market 2019-2024 ($M) - Regional Industry Research
14.3.1 Depression Market Estimate Forecast Market 2019-2024 ($M)
14.4 Dementia Market 2019-2024 ($M) - Regional Industry Research
14.4.1 Dementia Market Estimate Forecast Market 2019-2024 ($M)
LIST OF FIGURES
1.US Antipsychotic Drugs Market Revenue, 2019-2024 ($M)2.Canada Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
3.Mexico Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
4.Brazil Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
5.Argentina Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
6.Peru Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
7.Colombia Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
8.Chile Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
9.Rest of South America Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
10.UK Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
11.Germany Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
12.France Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
13.Italy Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
14.Spain Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
15.Rest of Europe Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
16.China Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
17.India Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
18.Japan Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
19.South Korea Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
20.South Africa Antipsychotic Drugs Market Revenue, 2019-2024 ($M)
21.North America Antipsychotic Drugs By Application
22.South America Antipsychotic Drugs By Application
23.Europe Antipsychotic Drugs By Application
24.APAC Antipsychotic Drugs By Application
25.MENA Antipsychotic Drugs By Application
26.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Geographic Foothold, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Pfizer, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Eli Lilly Co, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Glaxo Smithkline, Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Allergan, Sales /Revenue, 2015-2018 ($Mn/$Bn)